Abstract
Purpose
Cheyne–Stokes respiration during sleep is associated with increased mortality in heart failure. The magnitude of oxidative stress is a marker of disease severity and a valuable predictor of mortality in heart failure. Increased oxidative stress associated with periodic breathing during Cheyne–Stokes respiration may mediate increased mortality in these patients. We hypothesized that the presence of Cheyne–Stokes respiration is associated with oxidative stress by increasing the formation of reactive oxygen species in patients with heart failure.
Methods and results
Twenty-three patients with heart failure [left ventricular ejection fraction 30.2 ± 9% (mean ± standard deviation)] and 11 healthy controls underwent nocturnal polysomnography. Subjects with obstructive sleep apnea were excluded. The majority (88%) of patients with heart failure had Cheyne–Stokes respiration during sleep. The intensity of oxidative stress in neutrophils was greater in patients with heart failure (4,218 ± 1,706 mean fluorescence intensity/cell vs. 1,003 ± 348 for controls, p < 0.001) and correlated with the duration of Cheyne–Stokes respiration. Oxidative stress was negatively correlated with SaO2 nadir during sleep (r = −0.43, p = 0.039). The duration of Cheyne–Stokes respiration predicted severity of oxidative stress in patients with heart failure (beta = 483 mean fluorescence intensity/cell, p < 0.02).
Conclusions
Levels of oxidative stress are increased in patients with heart failure and Cheyne–Stokes respiration during sleep compared with healthy controls. The duration of Cheyne–Stokes respiration predicts the magnitude of oxidative stress in heart failure. Increased oxidative stress may mediate increased mortality associated with Cheyne–Stokes respiration in patients with heart failure.
Similar content being viewed by others
References
Mortara A, Sleight P, Pinna GD, Maestri R, Capomolla S, Febo O, La Rovere MT, Cobelli F (1999) Association between hemodynamic impairment and Cheyne–Stokes respiration and periodic breathing in chronic stable congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 84(8):900–904. doi:S0002-9149(99)00462-2
Fanfulla F, Mortara A, Maestri R, Pinna G, Bruschi C, Cobelli F, Rampulla C (1998) The development of hyperventilation in patients with chronic heart failure and Cheyne–Stokes respiration. Chest 114(4):1083–1090. doi:10.1378/chest.114.4.1083
Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, Roselle GA (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154–2159
Lofaso F, Verschueren P, Rande J, Harf A, Goldenberg F (1994) Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 106(6):1689–1694. doi:10.1378/chest.106.6.1689
Bradley TD, Floras JS (2003) Sleep apnea and heart failure. Part II: central sleep apnea. Circulation 107(13):1822–1826. doi:10.1161/01.cir.0000061758.05044.64
Hanly P, Zuberi-Khokhar N (1996) Increased mortality associated with Cheyne–Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153(1):272–276
Francis DP, Willson K, Davies LC, Coats AJS, Piepoli M (2000) Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation 102(18):2214–2221
Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, Giannuzzi P (1999) Prognostic value of nocturnal Cheyne–Stokes respiration in chronic heart failure. Circulation 99(11):1435–1440
Fanfulla F, Mortara A, Maestri R, Pinna GD, Bruschi C, Cobelli F, Rampulla CU (1998) The development of hyperventilation in patients with chronic heart failure and Cheyne–Stokes respiration: a possible role of chronic hypoxia. Chest 114(4):1083–1090
Corra U, Pistono M, Mezzani A, Braghiroli A, Giordano A, Lanfranchi P, Bosimini E, Gnemmi M, Giannuzzi P (2006) Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation 113(1):44–50. doi:10.1161/circulationaha.105.543173
Bradley TD (2003) The ups and downs of periodic breathing: Implications for mortality in heart failure. J Am Coll Cardiol 41(12):2182–2184. doi:10.1016/s0735-1097(03)00470-4
Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC (2002) Acc/aha guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant 21(2):189–203. doi:S1053249801007768
Remme WJ, Swedberg K (2002) Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 4(1):11–22. doi:S1388984201002318
Guyatt G, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB (1985) The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 8(132):919–923
Lipkin DP, Scriven A, Crake T, Poole-Wilson PA (1986) Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) 292(6521):653–655
Krieger AC, Ayappa I, Norman RG, Rapoport DM (2000) Central vs. Obstructive respiratory events classified by nasal cannula/pressure transducer. Am J Respir Crit Care Med 161:A28, Abstract
Himmelfarb J, Hakim RM, Holbrook DG, Leeber DA, Ault KA (1992) Detection of granulocyte reactive oxygen species formation in whole blood using flow cytometry. Cytometry 13(1):83–89
Bass D, Parce J, Dechatelet L, Szejda P, Seeds M, Thomas M (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130(4):1910–1917
Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 Focused update incorporated into the acc/aha 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53(15):e1–e90. doi:10.1016/j.jacc.2008.11.013
Hanly PJ, Zuberi-Khokhar NS (1996) Increased mortality associated with Cheyne–Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153(1):272–276
Javaheri S, Shukla R, Zeigler H, Wexler L (2007) Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 49(20):2028–2034. doi:10.1016/j.jacc.2007.01.084
Eleuteri EMF, Gnemmi I, Carbone M, Colombo M, La Rocca G, Anzalone R, Tarro Genta F, Zummo G, Di Stefano A, Giannuzzi P (2009) Role of oxidative and nitrosative stress biomarkers in chronic heart failure. Front Biosci 14:2230–2237
Michowitz Y, Kisil S, Guzner-Gur H, Rubinstein A, Wexler D, Sheps D, Keren G, George J (2008) Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure. IMAJ 12:884–888
Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, Jeejeebhoy KN (1998) Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31(6):1352–1356. doi:S0735-1097(98)00101-6
Mak S, Newton GE (2001) The oxidative stress hypothesis of congestive heart failure: radical thoughts. Chest 120(6):2035–2046
Poletti R, Passino C, Giannoni A, Zyw L, Prontera C, Bramanti F, Clerico A, Piepoli M, Emdin M (2009) Risk factors and prognostic value of daytime Cheyne–Stokes respiration in chronic heart failure patients. Int J Cardiol 137(1):47–53
Tan S, Zhou F, Nielsen VG, Wang Z, Gladson CL, Parks DA (1999) Increased injury following intermittent fetal hypoxia–reoxygenation is associated with increased free radical production in fetal rabbit brain. J Neuropathol Exp Neurol 58(9):972–981
La Rocca G, Di Stefano A, Eleuteri E, Anzalone R, Magno F, Corrao S, Loria T, Martorana A, Di Gangi C, Colombo M, Sansone F, Patanè F, Farina F, Rinaldi M, Cappello F, Giannuzzi P, Zummo G (2009) Oxidative stress induces myeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure. Basic Res Cardiol 104(3):307–320
Takenaka H, Kihara Y, Iwanaga Y, Onozawa Y, Toyokuni S, Kita T (2006) Angiotensin ii, oxidative stress, and extracellular matrix degradation during transition to lv failure in rats with hypertension. J Mol Cell Cardiol 41(6):989–997
Zhang P, Hou M, Li Y, Xu X, Barsoum M, Chen Y, Bache RJ (2009) Nadph oxidase contributes to coronary endothelial dysfunction in the failing heart. Am J Physiol Heart Circ Physiol 296(3):H840–H846. doi:10.1152/ajpheart.00519.2008
Prabhakar NR (2001) Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol 90(5):1986–1994
Gottlieb JD, Schwartz AR, Marshall J, Ouyang P, Kern L, Shetty V, Trois M, Punjabi NM, Brown C, Najjar SS, Gottlieb SS (2009) Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure. J Am Coll Cardiol 54(18):1706–1712. doi:10.1016/j.jacc.2009.08.016
Fletcher EC, Lesske J, Qian W, Miller CC, Unger T (1992) Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19(6 Pt 1):555–561
Bao G, Metreveli N, Li R, Taylor A, Fletcher EC (1997) Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 83(1):95–101
Floras JS (2009) Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 54(5):375–385. doi:10.1016/j.jacc.2009.03.061
Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165(7):934–939
Bitter T, Westerheide N, Faber L, Hering D, Prinz C, Langer C, Horstkotte D, Oldenburg O (2010) Adaptive servoventilation in diastolic heart failure and Cheyne–Stokes respiration. Eur Respir J 36:385–392. doi:10.1183/09031936.00045609
Oldenburg O, Bitter T, Schmidt A, Wellmann B, Lehmann R, Prinz C, Langer C, Horstkotte D (2008) Treatment of nocturnal cheyne - stokes - respiration by adaptive servoventilation improves sleep disordered breathing and cardiopulmonary function in patients with chronic heart failure. Circulation 118 (18):S717A (abstract)
Olson LJ, Somers VK (2007) Treating central sleep apnea in heart failure: outcomes revisited. Circulation 115(25):3140–3142. doi:10.1161/circulationaha.107.709303
Scharf C, Turk A, Brack T, Bloch K (2005) Cardiac resynchronization therapy, central sleep apnea, and Cheyne–Stokes respiration in chronic heart failure patients. J Am Coll Cardiol 45(4):633. doi:10.1016/j.jacc.2004.11.028
Sinha A-M, Skobel EC, Breithardt O-A, Norra C, Markus KU, Breuer C, Hanrath P, Stellbrink C (2004) Cardiac resynchronization therapy improves central sleep apnea and Cheyne–Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 44(1):68–71. doi:10.1016/j.jacc.2004.03.040
Stellbrink C, Skobel E, Sinha A-M (2005) Cardiac resynchronization therapy, central sleep apnea, and Cheyne–Stokes respiration in chronic heart failure patients: reply. J Am Coll Cardiol 45(4):633–634. doi:10.1016/j.jacc.2004.11.027
Andreas S, Weidel K, Hagenah G, Heindl S (1998) Treatment of Cheyne–Stokes respiration with nasal oxygen and carbon dioxide. Eur Respir J 12(2):414–419
Franklin KA, Eriksson P, Sahlin C, Lundgren R (1997) Reversal of central sleep apnea with oxygen. Chest 111(1):163–169
Krachman SL, D'Alonzo GE, Berger TJ, Eisen HJ (1999) Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne–Stokes respiration during sleep in congestive heart failure. Chest 116(6):1550–1557
Soll BA, Yeo KK, Davis JW, Seto TB, Schatz IJ, Shen EN (2009) The effect of posture on Cheyne–Stokes respirations and hemodynamics in patients with heart failure. Sleep 32(11):499–506
Lorenzi-Filho G, Rankin F, Bies I, Bradley TD (1999) Effects of inhaled carbon dioxide and oxygen on Cheyne–Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 159(5):1490–1498
Andreas S, Clemens C, Sandholzer H, Figulla H, Kreuzer H (1996) Improvement of exercise capacity with treatment of Cheyne–Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 27(6):1486–1490
Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD (1995) Effects of nasal cpap on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152(2):473–479
Acknowledgements
We would like to thank Ming Chen and Vanessa Coradin at the NYU Sleep Disorder Center for assistance in the performance and scoring of the sleep studies, Daniel Meyer and Michael Gregory at the Flow Cytometry Core for their contribution in performing the flow cytometry analyses, and Dr. Robert Kaner for his valuable comments in reviewing the manuscript.
Grant support
American Heart Association National Center, Scientist Development Award and National Institutes of Health.
Conflict of interest
None of the authors has a conflict of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krieger, A.C., Green, D., Cruz, M.T. et al. Predictors of oxidative stress in heart failure patients with Cheyne–Stokes respiration. Sleep Breath 15, 827–835 (2011). https://doi.org/10.1007/s11325-010-0444-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-010-0444-2